Case report shows improvement in hepatic encephalopathy symptoms in a patient with portal hypertension, suggesting PSE may be an effective intervention.
A 59-year-old woman presented with frequent episodes of hepatic encephalopathy due to cirrhosis caused by primary biliary cholangitis and a large splenorenal shunt, leading to repeated hospital admissions. We administered maximal medical therapy and enemas to prevent constipation, but her situation did not improve. Subsequently, balloon-occluded retrograde transvenous obliteration (BRTO) was considered;however, because the splenorenal shunt was large and liver function was poor (Child-Pugh C), BRTO might have caused a sudden rise in portal venous pressure and uncontrolled ascites. Therefore, we performed partial splenic artery embolization (PSE), embolizing 43% of the splenic volume, mainly in the lower portion. After PSE, her blood-ammonia level fell and consciousness improved. Since then, she has been hospitalized only once for recurrent encephalopathy. PSE-commonly used for hypersplenism or portal hypertension-decreases splenic venous return and portal pressure, thereby reducing splenorenal-shunt flow and directing ammonia-laden blood to the liver. Thus, PSE is a useful treatment option for hepatic encephalopathy, particularly in patients with large portosystemic shunts.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: